Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Clinical trial NCT01574170 · COMPLETED
Trial details
- NCT number
- NCT01574170
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-18
- Primary completion
- 2023-05-31
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.